posted on 2023-03-31, 02:05authored byThomas F. Eleveld, Linda Schild, Jan Koster, Danny A. Zwijnenburg, Lindy K. Alles, Marli E. Ebus, Richard Volckmann, Godelieve A. Tijtgat, Peter van Sluis, Rogier Versteeg, Jan J. Molenaar
Supplementary Table 1: Public datasets used in this study, Supplementary Table 2: gRNA sequences against CIC, NF1 and DMD, Supplementary Table 3: Primers used for RT-qPCR experiments, Supplementary Table 4: Genes differentially expressed in the various model systems, Supplementary Table 5: Enrichment analysis of Hallmark gene sets , Supplementary Table 6: Statistical analysis of the role of RAS-MAPK activation in survival, Supplementary Table 7: Known RAS-MAPK activating mutations in our tumor series